Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical Practice

Renal cell carcinoma (RCC) is the seventh most common cancer in men and the ninth most common cancer in women worldwide. There is plenty of evidence about the role of the immune system in surveillance against tumors. Thanks to a better understanding of immunosurveillance mechanisms, immunotherapy ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Lasorsa, Francesco, di Meo, Nicola Antonio, Rutigliano, Monica, Milella, Martina, Ferro, Matteo, Pandolfo, Savio Domenico, Crocetto, Felice, Tataru, Octavian Sabin, Autorino, Riccardo, Battaglia, Michele, Ditonno, Pasquale, Lucarelli, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136190/
https://www.ncbi.nlm.nih.gov/pubmed/37189689
http://dx.doi.org/10.3390/biomedicines11041071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136190/
https://www.ncbi.nlm.nih.gov/pubmed/37189689
http://dx.doi.org/10.3390/biomedicines11041071

Ejemplares similares